Smartphone-based immunoassay holds promise for at-home DR screening

• Posted on: Jun 16 2020
• By: Saratoga Opthalmology
• Leave a response

This study evaluated a smartphone-based, gold nanoparticle-based immunoassay paper sensor for identifying a biomarker for diabetic retinopathy (DR).
Source: AAO

Posted in: Uncategorized